Sanofi gains EMA Orphan Drug status for efdoralprin alfa, a phase II biologic for AATD-related emphysema with promising dosing data.
Morning Overview on MSN
A tiny gut-made molecule could rewrite diabetes care
A small molecule made by gut microbes is rapidly emerging as one of the most intriguing new levers for controlling blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback